Skip to main content
. 2022 Oct 14;12:967450. doi: 10.3389/fonc.2022.967450

Table 1.

Basic clinical characteristics of all patients.

Variables All patients (n=163) CR/PR (n=112) SD (n=31) PD (n=20) p a
Age (y) 27 (7~40) 25 (7~40) 28 (9~39) 31.5 (9~40) 0.099
Sex, male (%) 98 (60.12) 66 (58.93) 19 (61.29) 13 (65.00) 0.673
TNM stage, n (%) 0.917
I 69 (42.33) 48 (42.86) 13 (41.94) 8 (40.00)
II 53 (32.52) 37 (33.04) 10 (32.26) 6 (30.00)
III 41 (25.15) 27 (24.11) 8 (25.81) 6 (30.00)
Site of tumor, n (%) 0.643
Femur 84 (51.53) 56 (50.00) 17 (54.84) 11 (55.00)
Tibia/fibula 36 (22.09) 25 (22.32) 7 (22.58) 4 (20.00)
Humerus 21 (12.88) 16 (14.29) 3 (9.68) 2 (10.00)
Pelvis 12 (7.36) 9 (8.04) 2 (6.45) 1 (5.00)
Head/neck 9 (5.52) 5 (3.07) 2 (6.45) 2 (10.00)
Other 1 (0.61) 1 (0.89) 0 (0) 0 (0)
Necrosis, n (%)
Good (≥90%) 52 (31.90)
Poor (<90%) 111 (68.10)
a

Comparison for continuous data were analyzed by Kruskal-Wallis test post hoc for comparison among three or more groups for non-normally distributed data (age). Rates were compared by Chi square test.